Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,767 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Differences among hemoglobin thresholds for red blood cell transfusions in patients with hematological diseases in teaching hospitals: a real world data in Japan.
Yokohama A, Okuyama Y, Ueda Y, Itoh M, Fujiwara SI, Hasegawa Y, Nagai K, Arakawa K, Miyazaki K, Makita M, Watanabe M, Ikeda K, Tanaka A, Fujino K, Matsumoto M, Makino S, Kino S, Takeshita A, Muroi K. Yokohama A, et al. Among authors: hasegawa y. Int J Hematol. 2020 Oct;112(4):535-543. doi: 10.1007/s12185-020-02937-3. Epub 2020 Jul 18. Int J Hematol. 2020. PMID: 32683598
A national survey of premedication for transfusion reactions in Japan.
Fujiwara SI, Kino S, Tanaka A, Hasegawa Y, Yokohama A, Fujino K, Shigeyoshi M, Matsumoto M, Takeshita A, Muroi K; Clinical Research Support Committee, The Japan Society of Transfusion Medicine Cell Therapy. Fujiwara SI, et al. Among authors: hasegawa y. Transfus Apher Sci. 2017 Oct;56(5):708-712. doi: 10.1016/j.transci.2017.07.024. Epub 2017 Sep 11. Transfus Apher Sci. 2017. PMID: 28941883
Released washed platelet concentrates are effective and safe in patients with a history of transfusion reactions.
Fujiwara SI, Fujishima N, Kanamori H, Ito M, Sugimoto T, Saito S, Sakaguchi T, Nagai K, Masuoka H, Nagai K, Morita A, Kino S, Tanaka A, Hasegawa Y, Yokohama A, Fujino K, Makino S, Matsumoto M, Takeshita A, Muroi K. Fujiwara SI, et al. Among authors: hasegawa y. Transfus Apher Sci. 2018 Dec;57(6):746-751. doi: 10.1016/j.transci.2018.09.001. Epub 2018 Sep 7. Transfus Apher Sci. 2018. PMID: 30224152
A Japanese multi-institutional collaborative study of antigen-positive red blood cell (RBC) transfusions in patients with corresponding RBC antibodies.
Yamada C, Takeshita A, Ohto H, Ishimaru K, Kawabata K, Nomaguchi Y, Haraguchi Y, Abe M, Sobue K, Takenouchi H, Takadate J, Kamimura M, Katai A, Kasai D, Minami Y, Sugimoto T, Michino J, Nagai K, Kumagai M, Hasegawa Y, Ishizuka K, Ohtomo N, Yamada N, Muroi K, Matsushita T, Takahashi K. Yamada C, et al. Among authors: hasegawa y. Vox Sang. 2020 Jul;115(5):456-465. doi: 10.1111/vox.12906. Epub 2020 Mar 2. Vox Sang. 2020. PMID: 32124460 Clinical Trial.
[Acute painful crisis in a female Nigerian patient with sickle cell disease].
Nin S, Seki M, Maie K, Kuroda A, Miyamoto K, Ogawa S, Ito Y, Kurita N, Yokoyama Y, Sakata Yanagimoto M, Obara N, Hasegawa Y, Ogino Y, Ito T, Chiba S. Nin S, et al. Among authors: hasegawa y. Rinsho Ketsueki. 2015 Jan;56(1):30-4. doi: 10.11406/rinketsu.56.30. Rinsho Ketsueki. 2015. PMID: 25745965 Japanese.
High efficacy of eculizumab treatment for fulminant hemolytic anemia in primary cold agglutinin disease.
Makishima K, Obara N, Ishitsuka K, Sukegawa S, Suma S, Kiyoki Y, Baba N, Sakamoto T, Kato T, Kusakabe M, Nishikii H, Kurita N, Yokoyama Y, Sakata-Yanagimoto M, Hasegawa Y, Chiba S. Makishima K, et al. Among authors: hasegawa y. Ann Hematol. 2019 Apr;98(4):1031-1032. doi: 10.1007/s00277-018-3521-4. Epub 2018 Oct 15. Ann Hematol. 2019. PMID: 30324459 No abstract available.
4,767 results